Search - tctmd.com

Displaying 401 - 420 of 852

Sort: Relevancy | Date

No Very Late Scaffold Thrombosis Risk With Absorb BVS in China, Japan

News Conference News EuroPCR 2017

No Very Late Scaffold Thrombosis Risk With Absorb BVS Studies in China, Japan

Michael O'Riordan

May 17, 2017

News Daily News

Novel Percutaneous Technique May Allow for TMVR in Patients at High Risk for LVOT Obstruction

Yael L. Maxwell

April 18, 2017

News Daily News

Rapid Rule-Out Strategy With High-Sensitivity Troponin Shows Promise Ahead of US Commercial Availability of Test

L.A. McKeown

April 17, 2017

News Daily News

PROMISE Analysis Boosts Gatekeeper Role for FFRCT in Symptomatic Stable CAD

Shelley Wood

April 12, 2017

News Daily News

Readmission for Critical Limb Ischemia Common and Largely Unplanned

L.A. McKeown

April 10, 2017

News Daily News

Crowdfunding Medical Care Poses Ethical Quandaries for Physicians

Yael L. Maxwell

April 05, 2017

News Daily News

SCOUTing the ‘Forgotten Valve’: Promise for a New Percutaneous Treatment Option in Tricuspid Regurgitation

Yael L. Maxwell

April 04, 2017

News Daily News

Using Coronary CTA to Evaluate Suspected CAD May Improve Patient Outcomes

Todd Neale

April 03, 2017

News Features

Living or Leaving: Does Palliative Care Deserve a Place at the TAVR Table?

Caitlin E. Cox

March 31, 2017

News Daily News

MitraClip for Tricuspid Regurgitation Gains Traction but Still in Preliminary Stages

Yael L. Maxwell

March 27, 2017

News Conference News ACC 2017

ABSORB III: Two-Year Results Show a Higher MACE Rate Compared With Xience

Michael O'Riordan

March 18, 2017

News Conference News ACC 2017

CARAT: Novel HDL Mimetic Fails to Show Benefit in Coronary Atherosclerosis After ACS

Yael L. Maxwell

March 18, 2017

News Conference News ACC 2017

Live From Washington: ACC 2017, Day Two

Shelley Wood

March 18, 2017

News Conference News ACC 2017

ORION-1: Novel LDL-Lowering Treatment Could Reduce Costs, Increase Adherence Over PCSK9s

Yael L. Maxwell

March 17, 2017

News Conference News ACC 2017

Live From Washington: ACC 2017, Day One

Shelley Wood

March 17, 2017

News Daily News

‘Hub and Spoke’ Model Promises to Improve Access to PCI for STEMI in Low- and Middle-Income Countries

L.A. McKeown

March 14, 2017

News Daily News

Mixed Clinical, Biomarker Score Might Boost CAD Risk Prediction

Yael L. Maxwell

March 03, 2017

News Daily News

Edward ‘Ted’ Diethrich, Founder of the Arizona Heart Institute, Dies at 81

L.A. McKeown

March 01, 2017

News Daily News

Four-in-One Blood Pressure Pill Shows Promise as Initial Therapy

Shelley Wood

February 24, 2017

News Conference News ISET 2017

Bioresorbable Scaffolds for PAD: Does the Strategy Have Legs?

Caitlin E. Cox

February 17, 2017

Advertisement

No Very Late Scaffold Thrombosis Risk With Absorb BVS Studies in China, Japan

Novel Percutaneous Technique May Allow for TMVR in Patients at High Risk for LVOT Obstruction

Rapid Rule-Out Strategy With High-Sensitivity Troponin Shows Promise Ahead of US Commercial Availability of Test

PROMISE Analysis Boosts Gatekeeper Role for FFRCT in Symptomatic Stable CAD

Readmission for Critical Limb Ischemia Common and Largely Unplanned

Crowdfunding Medical Care Poses Ethical Quandaries for Physicians

SCOUTing the ‘Forgotten Valve’: Promise for a New Percutaneous Treatment Option in Tricuspid Regurgitation

Using Coronary CTA to Evaluate Suspected CAD May Improve Patient Outcomes

Living or Leaving: Does Palliative Care Deserve a Place at the TAVR Table?

MitraClip for Tricuspid Regurgitation Gains Traction but Still in Preliminary Stages

ABSORB III: Two-Year Results Show a Higher MACE Rate Compared With Xience

CARAT: Novel HDL Mimetic Fails to Show Benefit in Coronary Atherosclerosis After ACS

Live From Washington: ACC 2017, Day Two

ORION-1: Novel LDL-Lowering Treatment Could Reduce Costs, Increase Adherence Over PCSK9s

Live From Washington: ACC 2017, Day One

‘Hub and Spoke’ Model Promises to Improve Access to PCI for STEMI in Low- and Middle-Income Countries

Mixed Clinical, Biomarker Score Might Boost CAD Risk Prediction

Edward ‘Ted’ Diethrich, Founder of the Arizona Heart Institute, Dies at 81

Four-in-One Blood Pressure Pill Shows Promise as Initial Therapy

Bioresorbable Scaffolds for PAD: Does the Strategy Have Legs?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content